Lymphadenopathy-associated virus: from molecular biology to pathogenicity.
about
Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus proteaseIs a positive western blot proof of HIV infection?Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitroPersistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.Transmission of human immunodeficiency virus from parents to only one dizygotic twinThirty years of the human immunodeficiency virus epidemic and beyond.Activation of human immunodeficiency virus by ultraviolet radiation.Molecular genetics and structure of the human immunodeficiency virus.A critical analysis of the HIV-T4-cell-AIDS hypothesis.Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV).The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.New CD4(+) cell line susceptible to infection by HIV-1.Expression of the T4 molecule (AIDS virus receptor) by human brain-derived cells.Selective expansion of a CD3+CD4-CD8- subpopulation in clinical groups associated with human immunodeficiency virus infection.Human immunodeficiency virus infection and the acquired immune deficiency syndrome: A review
P2860
Q27674531-F6724CD6-D5F3-4030-ADB0-FB2B71F4F01FQ34058940-B09D5D04-38EB-4515-BD69-0E9A638A30F4Q34619693-0A908C7E-AA68-47AE-8412-202A70F7804AQ35838898-71A7E592-DF64-46B9-9F6A-51B9A0A70878Q36860939-90E4D42D-52F8-44E8-9B33-476A3DCA9391Q37214651-87C08B38-FD54-472B-84E7-4D41D80A9ACAQ37667360-E2EF4928-D485-441F-AF8F-8910519C935DQ37793355-48E7FA5E-FCBD-4BBB-A51C-AB8C224622D0Q39573787-21A6E1A1-09CE-4045-A690-75532F702FB9Q40522019-E85D14F2-A313-4531-A4AF-74A424C7E589Q41453322-6C504F76-3281-4ACF-99FC-DDCEAE93E73BQ41768724-71DE4CAF-E371-4F86-8B98-B0B161ECC985Q42815234-14D341E4-B047-470B-9E1B-3552EAAE272EQ45831249-71B24717-4D81-45CE-A257-BD3731F1DE41Q45833985-8B99E098-1425-478D-AF9F-9D2E2091450BQ57672414-12C41928-A73E-4D7E-AED8-CD263F892776
P2860
Lymphadenopathy-associated virus: from molecular biology to pathogenicity.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Lymphadenopathy-associated virus: from molecular biology to pathogenicity.
@en
type
label
Lymphadenopathy-associated virus: from molecular biology to pathogenicity.
@en
prefLabel
Lymphadenopathy-associated virus: from molecular biology to pathogenicity.
@en
P1476
Lymphadenopathy-associated virus: from molecular biology to pathogenicity.
@en
P2093
Montagnier L
P304
P356
10.7326/0003-4819-103-5-689
P407
P577
1985-11-01T00:00:00Z